Zobrazeno 1 - 10
of 1 822
pro vyhledávání: '"A. Abnous"'
Publikováno v:
Research in Pharmaceutical Sciences, Vol 19, Iss 1, Pp 1-12 (2024)
Background and purpose: Alzheimer's disease (AD) is a common neurodegenerative disease and the fifth leading cause of death among the elderly. The development of drugs for AD treatment is based on inhibiting cholinesterase (ChE) activity and inhibiti
Externí odkaz:
https://doaj.org/article/1d11471833b04d098a5462237a825275
Autor:
Nourollahian, Tanin, Taghavi, Sahar, Abnous, Khalil, Taghdisi, Seyed Mohammad, Nekooei, Sirous, Ramezani, Mohammad, Alibolandi, Mona
Publikováno v:
In International Journal of Pharmaceutics 5 September 2024 662
Autor:
Jamshidi, Zahra, Dehghani, Sadegh, Nameghi, Morteza Alinezhad, Ramezani, Mohammad, Alibolandi, Mona, Abnous, Khalil, Taghdisi, Seyed Mohammad
Publikováno v:
In Journal of Drug Delivery Science and Technology September 2024 99
Autor:
Abbasi, Athena, Zahiri, Mahsa, Abnous, Khalil, Taghdisi, Seyed Mohammad, Aliabadi, Ali, Ramezani, Mohammad, Alibolandi, Mona
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics September 2024 202
Autor:
Feizpour, Rozita, Jabbari, Atena, Hadizadeh, Farzin, Alibolandi, Mona, Ramezani, Mohammad, Saberi, Mohammad Reza, Taghdisi, Seyed Mohammad, Abnous, Khalil
Publikováno v:
In International Journal of Pharmaceutics 15 August 2024 661
Publikováno v:
In Analytica Chimica Acta 15 August 2024 1317
Autor:
Khademi, Zahra, Yazdi, Katayoon Sarafraz, Ramezani, Mohammad, Alibolandi, Mona, Rezvani, Seyede Aysa, Abnous, Khalil, Taghdisi, Seyed Mohammad
Publikováno v:
In Journal of Pharmaceutical Sciences August 2024 113(8):2198-2207
Autor:
Imanimoghadam, Maryam, Yaghoobi, Elnaz, Alizadeh, Fatemeh, Ramezani, Mohammad, Alibolandi, Mona, Abnous, Khalil, Taghdisi, Seyed Mohammad
Publikováno v:
In Journal of Pharmaceutical Sciences July 2024 113(7):1865-1873
Autor:
Aref Abdollahzade, Hoda Rahimi, Elnaz Yaghoobi, Mohammad Ramezani, Mona Alibolandi, Khalil Abnous, Seyed Mohammad Taghdisi
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 26, Iss 10, Pp 1177-1187 (2023)
Objective(s): A targeted delivery platform was prepared to co-deliver both doxorubicin (Dox) as an anticancer drug and FOXM1 aptamer as a therapeutic substance to breast cancer cells (4T1 and MCF-7) to reduce Dox side effects and increase its therape
Externí odkaz:
https://doaj.org/article/786f72515b9b4d80bbf6ccc817e7eb75
Autor:
Mohammadi Zonouz, Aidin, Taghavi, Sahar, Nekooei, Sirous, Abnous, Khalil, Taghdisi, Seyed Mohammad, Ramezani, Mohammad, Alibolandi, Mona
Publikováno v:
In International Journal of Pharmaceutics 15 November 2024 665